Log in using OpenID

Gouty Arthritis Market

Gouty arthritis is characterized by intense joint pain due to deposition of uric acid crystals. Symptoms of gouty arthritis include redness and swelling of joints and intense pain.
Gouty Arthritis Market Global Industry Insights,
Trends, Outlook, and Opportunity Analysis, 20182026
Gouty arthritis is characterized by intense joint pain due to deposition of uric acid crystals.
Symptoms of gouty arthritis include redness and swelling of joints and intense pain. The
condition can be treated with the help of medication. Uric acid is deposited either due to its
excess intake or body’s inability to process it leading to inflammation of joint sites such as
ankles and toes or wrist. Untreated gouty arthritis may damage joints or kidney as excessive
accumulation of uric acid crystals would lead to kidney stone, kidney failure. In most cases, it
is observed with other metabolic diseases or conditions such as hypertension, obesity, and
Request Sample Copy of Research Report @
High prevalence of associated chronic diseases to provide growth to gouty arthritis market
Other comorbidities such as hypertension is often associated with gout. As per study published
in Journal of Rheumatology in 2014, around 75% of gouty arthritis patient were reported to be
suffering from hypertension. Therefore patients suffering from chronic disease are at high risk of
developing gouty arthritis .High prevalence of gouty arthritis is expected to drive the growth for
global gouty arthritis market. According to study published in British Medical Journal in 2017,
prevalence of gouty arthritis is 1% to 10% globally. Furthermore, factors such as increasing
consumption of high protein food worldwide, linked with gouty arthritis and increasing
awareness amongst people for early treatment of disease are the factors boosting growth of
gouty arthritis market.
North America holds dominant position in gouty arthritis market
Regional segmentation of gouty arthritis market by Coherent Market Insights consist of North
America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is
expected to dominate gouty arthritis market, owing high prevalence of gouty arthritis in the
U.S. According to Centre for Disease Control and Prevention (CDC), an estimated 54.4 million
patients annually suffered from some form of arthritis from 2013 - 2015, in which gouty
arthritis carries significant share. According to clinical guidelines for gout published in Annals
of Internal Medicine in 2017, about 3.9% of U.S. adults older than 20 years reported about
gout at least once in lifetime. Furthermore, increasing geriatric population is driving growth of
the market, owing to high prevalence of gouty arthritis in patients above 40 years of age. New
and effective therapies to treat gouty arthritis are expected to fuel growth of gouty arthritis
market. For instance, in 2015, Astra Zeneca received FDA approval for novel molecule lesinurad
(Zurampic), lesinurad is a urate transport inhibitor which inhibits URAT1, a protein responsible
for reabsorption of uric acid in kidneys, given in combination with xanthine oxidase inhibitor
helps achieve target serum uric acid level. Asia Pacific region is gaining significant traction in
this market, owing to increasing number of patients suffering from chronic diseases such as
diabetes and cardiovascular disease or chronic kidney disease, which are rising incrementally as
stated by WHO factsheet 2012,this is owing to established fact that around 75% hypertensive
patients had gouty arthritis as study published in Journal of Rheumatology in 2014.
Report includes chapters which deeply display the following deliverable about industry :
• Gouty Arthritis Market Research Objective and Assumption
• Gouty Arthritis Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Gouty Arthritis Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Gouty Arthritis Market, By Regions
• Gouty Arthritis Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Gouty Arthritis Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Gouty Arthritis Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Gouty Arthritis Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Request For Customization of Research Report @
players operating in the gouty arthritis market include AstraZeneca plc, Takeda
Pharmaceutical Company Ltd., Novartis AG; Savient Pharmaceuticals, GlaxoSmithKline plc,
Merck& Co. Inc., Teijin Pharma Ltd., Regeneron Pharmaceuticals, JW Pharmaceutical
Corporation, and Nippon Chemiphar Co. Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Alex Huge
Alex Huge414   documents Email
Health and Medicine
File Size
109 KB
arthritis, Gouty Arthritis Market
Report inappropriate content